Focus:
Analysis
-
30 March 2020
Coronavirus treatment: Vaccines/drugs in the pipeline for COVID-19
Here are the potential human coronavirus vaccines/drugs pharmaceutical companies across the world are developing following the Wuhan coronavirus outbreak (COVID-19).
-
17 February 2020
Covid-19: Pharmaceutical companies and agencies that partnered for coronavirus vaccine development
Pharmaceutical companies from across the world along with government agencies have partnered to develop a cure for the new coronavirus (Covid-19) that emerged from Wuhan, China.
-
7 February 2020
January’s top news stories
A Phase I clinical trial of monoclonal antibody (mAb) CIS43LS against malaria started the enrolment of healthy adults at the NIH Clinical Center in Bethesda, Maryland, US, and Acceleron Pharma...
-
3 January 2020
2019 top news stories
Athersys reports positive data from MultiStem cell therapy trial and CRISPR and Vertex treat first patient in gene-editing therapy trial. Clinicaltrialsarena.com wraps up the key headlines from 2019.
-
6 December 2019
November’s top news stories
Eli Lilly and Boehringer Ingelheim started a Phase III clinical trial, EMPULSE, to evaluate whether Jardiance (empagliflozin) improves acute heart failure, and The Janssen Pharmaceutical Companies of Johnson & Johnson...
-
25 November 2019
Exploring efficiencies from eTMF with Cancer Research UK
Creating electronic versions of documents and processes underlying clinical trials is becoming the norm. Cancer Research UK’s Stephen Nabarro walk us through its implementation of Veeva Vault eTMF two years...
-
8 November 2019
October’s top news stories
GSK has initiated the Phase III EAGLE programme of gepotidacin for the treatment of uncomplicated urinary tract infection and urogenital gonorrhoea, and AstraZeneca has reported that a combination of Imfinzi...
-
5 October 2019
September’s top news stories
NIH kick starts hunt for neuroprotective stroke treatments and Denali begins dosing Parkinson’s patients in Phase Ib trial. Clinicaltrialsarena.com wraps up the key headlines from September 2019.
-
5 September 2019
August’s top news stories
Biopharmaceutical firm Retrophin reported that the Phase III clinical trial of fosmetpantotenate failed to meet endpoints in pantothenate kinase-associated neurodegeneration (PKAN) patients; and MyoKardia has commenced dosing of patients in...
-
8 July 2019
June’s top news stories
AstraZeneca’s human monoclonal antibody Imfinzi (durvalumab) improved overall survival in the Phase III CASPIAN trial in first-line extensive-stage small cell lung cancer (SCLC).